Shuta Ohara

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments

T. Koga, Kenichi Suda, Toshio Fujino et al. · Journal of Thoracic Oncology · 2021 · 231 citations · Full text

Vitro Experiments, Kras Secondary Mutations, Novel Therapy +9

Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro

Toshio Fujino, Yoshihisa Kobayashi, Kenichi Suda et al. · Journal of Thoracic Oncology · 2019 · 171 citations · Full text

Medicine, Pharmacology, Cancer Genomics +8

Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study

T. Koga, Yoshihisa Kobayashi, Kenji Tomizawa et al. · Lung Cancer · 2018 · 67 citations · Full text

EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib

Yoshihisa Kobayashi, Toshio Fujino, Masaya Nishino et al. · Journal of Thoracic Oncology · 2018 · 62 citations

Egfr T790m, Somatic Variant, Acquired Resistance +9

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study

Shuta Ohara, Kenichi Suda, Kazuko Sakai et al. · Translational Lung Cancer Research · 2020 · 59 citations · Full text